Focused on solving unmet needs in ophthalmology

Addressing significant unmet medical needs for better topical therapy
Adobe Illustrator 24.0 (Macintosh) 2019-12-03T14:45:21+01:00 256 100 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAZAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9Uc0/mH34q7mn8w+/FXc 0/mH34q7mn8w+/FXc0/mH34q7mn8w+/FWJ/8q80ZLeG3ttQv7WGJSvpw3AVX5LQl1KsDU1anSpO1 NslxIpEJ5KsluTcHVb9239NWmj4x1ieEenSMcaJIdx3AJqRgtKHb8vtPeK4il1nUpFudpA1wlAlK FFQRhOLdxxw8SKWw/lzpUMTRJq2o8TXj/pCVUkItVpH1CxgL4dseJaZRZwxWtpBarK0iwRrEJJW5 SMEULydu7Gm5yKUFrOiWeqtA8tzNbvbh/Te3kEbVkAFa0PTiCMIKpLL+Xely19XVtSkVuJaN7oOh K8TXiykdUrt4nDxIpZB+Xlr6Z+ua1fTz8uQlWUIFNXIKhhIQR6nWvYY8S0iovI9gk9rK2rahKLSR JhFLcK0bvGyOPUUpvvGvSmC1pD/8q60n0Iof0pqBSAMIa3CEqW7rVPhp2ph4lpc35e6aZ/X/AExq QmNQXW4QGhk9QrtH9mo6dMeJaV9O8l2VjrCammo3UrRuzrBNIHj+KJohXapKhqBq/ZCjtgtaRute W9O1a6hupbie3uLdeEUtvII2Cl1dhWh+1wofbEFKWN+X+mlFUavqQAXg/wDpKkOtKEOGRgajHiRT h+X+mKyuuq6gsi/7sWdA3HmX41CfZ+KlPADHiWmR6fbRWVnFarO8yxDiskz85CK1FW2rTpgSiOaf zD78VYq35e6Ktw89tf3tm8p5Ti3nVRI3rNNVgVP7TkbdsPEikfo/lmy0t4pFvrq7eLlxa7mEp+NE Q/sr2jHTElKd80/mH34FSjXPLmk61Jby3byLNaBxbywycGQuyMWFO/7oDCCqBtvJNjDcidtW1GYg lvTkuAUPL1DQqqrUfvfwGNoTnSdPtNL06Gwt5C0MAIRpCCxqxbcgKO/hgSqX9ta31hc2M7fuLqJ4 ZeJoeEilWofkcVY6fIGlKVFvqeoWkCEmO2huQsa1dXoKqzfs069PfDxIpMLHyxp1pd2l2tzPNNZx +kjTSK5YBClXJHImh8cbSl+s+cLLStQSynt5nZvSrIgQgCYuAQpYOwHpnkQtB88QFQM/5k6HCH5w XQdSFRDFQuTH6gA39qHwPXqMPCi117+Y+g2N1dQXcdxF9VnNu0gRXVmA3K8WJp9G3fHhW020HzFp 2uW8k9iJAkTBGEqGM1ZQ4pXrs2Aiko2/uTa2NxcqnqNBE8gjH7RRS1PppiBZRI0LfJ+r+Z9e1e+k vb69lkmkJNObBFB/ZRQaKo8Bm9hijEUA8bk1OSZskp1Y+V9RutOhvjqrKJYmm9JBLI9A6p8IU1bj y5SU+yMrlkANU5mPTTlES4+fvP48+5u98lXsUN1cT6rE31Z54kUvzd/q8DT7hWf0y3AgK9D3xjmG wpGTRyAJMuV/YLYql1dIKJM6jwViP1HL+EOAMkhyJXfXr3/lol/4Nv648I7k+LPvLvr17/y0S/8A Bt/XHhHcviz7yy+/0vUNa8565bRailkLb1bjlcSsiMEdV4LSvxHnsMxoyEYA1bsMkJ5M8oiVVv8A ciF/LvWhYveTa/aRxx7sguHd6CMO1FWv2DyRvcYPHjdcLMaHJVmf2oceSdVa+itI9dtmMwZklMzr HRFRviZqBW/edDh8aNXwsfyc7rj+9dL5D1qP0663bMJOO6XDMEBpz9Qj7PDeoPgfDEZ49yTosn8/ 7Vk3kfXIbd5pNZtlKOyCL6wxkIWcQ8uIqQGB9Ra9V3x8aPcj8nkr6/t8/wAFFr+W+ts8iJ5gs+a/ CqtcOlWpJSpIoATFQHxOD8xH+az/ACGT+f8Aax/zNpGqaDdRwSaml4JQxEltMzqOLlaN3BKhXHsw y3HITHJw9TjniNGV/FJvr17/AMtEv/Bt/XLeEdzj+LPvLvr17/y0S/8ABt/XHhHcviz7y769e/8A LRL/AMG39ceEdy+LPvLvr17/AMtEv/Bt/XHhHcviz7y769e/8tEv/Bt/XHhHcviz7y769e/8tEv/ AAbf1x4R3L4s+8u+vXv/AC0S/wDBt/XHhHcviz7y769e/wDLRL/wbf1x4R3L4s+8u+vXv/LRL/wb f1x4R3L4s+8u+vXv/LRL/wAG39ceEdy+LPvLvr17/wAtEv8Awbf1x4R3L4s+8vqbyEzN5K0RmJZj Zwkk7kngM0ef6z73rtKbxR/qhPsqch2KuxV2KrZI45Y2jkUPG4KujAFSpFCCD1BxV0UUcUaxxII4 0AVEUAKANgAB0xVdir5783aJ+VEeu3KWus3FqQ59a3t4PrEKPX4ljeqbA9qnNtinl4eTzmpw6XjP qI9wsJN+iPy1/wCphvf+kH/r5lnHl/mj5tHhab+efkoT6X+X6uBFr16y03P1BTv9M6fqwiWT+aPm xli0/SZ/0q6DSvy8YH1devVNdv8AQAP1TPiZ5P5o+axxafrM/wClVf0R+Wv/AFMN7/0g/wDXzBx5 f5o+bLwtN/PPyd+iPy1/6mG9/wCkH/r5jx5f5o+a+Fpv55+SaeaNL/L9/MOoPda5dw3DTMZYls+a q1dwG5iuV4pZOEUB82/U48ByHikQfclf6I/LX/qYb3/pB/6+ZZx5f5o+bR4Wm/nn5O/RH5a/9TDe /wDSD/18x48v80fNfC0388/J36I/LX/qYb3/AKQf+vmPHl/mj5r4Wm/nn5O/RH5a/wDUw3v/AEg/ 9fMePL/NHzXwtN/PPyd+iPy1/wCphvf+kH/r5jx5f5o+a+Fpv55+Tv0R+Wv/AFMN7/0g/wDXzHjy /wA0fNfC0388/J36I/LX/qYb3/pB/wCvmPHl/mj5r4Wm/nn5O/RH5a/9TDe/9IP/AF8x48v80fNf C0388/J36I/LX/qYb3/pB/6+Y8eX+aPmvhab+efk79Eflr/1MN7/ANIP/XzHjy/zR818LTfzz8nf oj8tf+phvf8ApB/6+Y8eX+aPmvhab+efk79Eflr/ANTDe/8ASD/18x48v80fNfC0388/J36I/LX/ AKmG9/6Qf+vmPHl/mj5r4Wm/nn5O/RH5a/8AUw3v/SD/ANfMePL/ADR818LTfzz8nfoj8tf+phvf +kH/AK+Y8eX+aPmvhab+efkyHyr+VnlbzRHcSaVrtw62pVZfUtQm7gkUrJ/k5Tl1M4cw5ODs/FlB MZHbyT7/AKF4sv8Aq9y/8iF/5ryv8+e5yP5Gh/OL0/QdKXSNGstMWQzLZwpCJSOJYIKVpU0zBnLi JPe7XFj4IiPcEfkWx2KuxV2KuxV2KqF/FNNY3MMDcJpInSJ604sykKa+xwg7okNnyFe2V3Y3ctpd xNBcwMUlicUZWHY50EZAiw8ROBiaOxDILLW/K0WmQwS6ZyvUiZXuWRZB6nqBqlS6cw6gruRw/Zym UJ3z2c2GfCIgGPqrnz/H6F1xrvlEwXSQaQ3qzPO0c0nA8RJA0cXBUCBAkhVuPxeNSaYiE9t1lnw0 ajzvu7v1sWy9wHYq7FWY39/oVl551mTWrBtRtHaaNIVcxlZGYUcMPAVzGjGRxjhNOyyzhHPIzHEG v095AN00zaFL6XDglusnFeQ9NvULVJNSjLx8GO/TD4eSua+Pp7vgKs/mD8takJ5dnCVVUJnqeAiM ZJ3+1zPqfMU6YPDy/wA5Pj6b+YVsXmL8vSFa58uMZKuJPSmdBxIcJxq5AK8gdwan5UL4eT+cv5jT 9Yfj5rLLX/y+igRbjy/LNMsgZpDMaFRKzkcQR+w/Cn+SDXriceT+ciOfTjnArItd8gj4ZPL8nHnI VZZ2JCNP6sankTXjGoj9wxNagYTDJ/OYxz6f+Z+L/AXjzB+X51J5W8uv9Rdlb6v6zVUBX5AEMpoz Mv7W1O/ceHkr6t2X5jT39Gynaaz5CileS40aa4Uj4YuZQKeRb7Svv1pUjoOm+xMMnegZtP1gfx8V eTzB+XTzuf8ADsscBMbRhZzyUhquDU/EGBPh0Hvg8PJ/OZHUaf8AmKEGs+QEt0jfQ5jKGk5TGVmJ Rpgybc1XksXw9OvWtdiYZO9hHNpwPoP4Pv7l8et/l6s07SaHNJHM/KNPV4+kgVlCCjVavPmTUbqB 748GTvZePp7+gtW+t+QI7GKKbQ5ZrkRCOWX1CoZ/SCmQUckH1Byp3r26YmGS+aI59OI0YG/x5omf zH+WnEJb+WpOPJSDJM3ILyBcVD71WqrXp13yIx5f5zM6jTdIfj5sKmcSSvIEEYdiwjWvFQTWgrXY ZlB1kjZtZih2Kvbf+ceP94tb/wCMsH/EXzW6/mHoexvol73r2a93LsVdirsVdirsVdirsVU7ieK3 gknlPGKJWeRvBVFSfuwgWgmnzx5h/ODU9T1J54dNsBbrVYBc26Ty8AduTvXf2G2bbHpABzLzebtW UpbRjXmHW/mXzrcQJcQ6DpzwyIZEk+oQAFQwSu/ixAHiemA4sY2s/NnHUZ5CxCNe5Sk1jzndNK66 HpxFu7QSldPtGAkRebICytVqHoDh4IDqfmWByZ5X6I7eQS2D8w9VhUhdP0o1Na/o+3H/ABFVyw6c Hqfm0R7QmP4Y/wClVf8AlZWr/wDVu0r/AKQYf6YPy0e8/Nl/KU+6Pyd/ysrV/wDq3aV/0gw/0x/L R7z81/lKfdH5J3rvnLzE3mbUbGw0ixvGhlbZbCOaTjyC8mIUk7sBXKoYY8IJJHxcnPq8niGMYg1/ RtDL5l89uoZPLNsysodSNJBBVjxDD4OhO1cl4WP+d9rD8zn/ANTH+lQNz+YHmG1ne3utI02C4jNJ IZdPiR1PgysARkhp4nkT82uWvyRNGMQf6qn/AMrK1f8A6t2lf9IMP9MP5aPefmx/lKfdH5O/5WVq /wD1btK/6QYf6Y/lo95+a/ylPuj8nf8AKytX/wCrdpX/AEgw/wBMfy0e8/Nf5Sn3R+Tv+Vlav/1b tK/6QYf6Y/lo95+a/wApT7o/J3/KytX/AOrdpX/SDD/TH8tHvPzX+Up90fk7/lZWr/8AVu0r/pBh /pj+Wj3n5r/KU+6Pyd/ysrV/+rdpX/SDD/TH8tHvPzX+Up90fk7/AJWVq/8A1btK/wCkGH+mP5aP efmv8pT7o/J3/KytX/6t2lf9IMP9Mfy0e8/Nf5Sn3R+Tv+Vlav8A9W7Sv+kGH+mP5aPefmv8pT7o /J3/ACsrV/8Aq3aV/wBIMP8ATH8tHvPzX+Up90fk7/lZWr/9W7Sv+kGH+mP5aPefmv8AKU+6Pyd/ ysrV/wDq3aV/0gw/0x/LR7z81/lKfdH5PVPyW8xXetWuqvcW9rbmF4QotYEgB5B/tcOvTMHV4xEi ncdm6g5IkkAe56TmG7J2KuxV2KuxV2KuxV2KrJ4Y54JIJRyjlUo48VYUOIKCLfOfmT8n/Memag8V m9vd2rEmCRriCCTh25pM8e/+rUZuMeriRvs8zn7LyRPp3HvWw+XfzIhtVtFFq1sqen6T3OmyKVqG AYPI3LiR8PL7PamJyYrv9aRh1IHDtX+aqy2v5nIZknurY/WS7SJLeaaw/eqY34q8h4hlqKLQYLxf gFJjqt7PPzikkf5eeaZBWOG1cDYlb+xP6pst/MQ/ALjDQZT0Hzj+tf8A8q383f8ALPb/APSdZf8A VbB+Zh3/AGFP8n5u77R+t3/Kt/N3/LPb/wDSdZf9VsfzMO/7Cv8AJ+bu+0frZBrHlfzzbeZ9WvNK EMS3jSRGT63ZKxicgkUeXkpqo8CMphlxmAB+4uXm0+cZZSh18wsuLH82bggzXELlXEgJu9O+2Jvr AP8AedpRy/swiWEf2FEoas8/vj32lWoeR/PWoXkt7eR28tzMeUkn1yxWpAp0WUAbDtlkc+MCh9xc fJo88zxSG/vj+tD/APKt/N3/ACz2/wD0nWX/AFWw/mYd/wBhY/yfm7vtH63f8q383f8ALPb/APSd Zf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yfm7vtH63f8q383f8ALPb/ APSdZf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yfm7vtH63f8q383f8A LPb/APSdZf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yfm7vtH63f8q38 3f8ALPb/APSdZf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yfm7vtH63f 8q383f8ALPb/APSdZf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yfm7vt H63f8q383f8ALPb/APSdZf8AVbH8zDv+wr/J+bu+0frd/wAq383f8s9v/wBJ1l/1Wx/Mw7/sK/yf m7vtH63q/wCSXl7VdGtNWTUI442mkhMfpzQz1Ch619F5Kde+YGsyCRFO57LwTxxIkOr03MN2jsVd irsVdirsVdirsVUL+WaGxuZYF5zxxO8SfzOqkqPpOEc0SOz5Dv7+81C8lvLyVp7mdi8srmpJOdBG IAoPEzmZmzuSn9l5a0GbTYbqXV0W5kiaRrUNArchIF41kkTiVU8qNTl+zXKZZJXVOZDTYzEEy37t v0n8dFdvKnlpVuW/T8DmKSVY0jZK8EjLoayGPmXb4fgqPfwHiy/msvyuLf1j7O78cmI5kOudirsV ZhqWkafqfnTXIr7Uo9MjiMs0c0oDK7q6gRirJuQxO1enTuMeEzGAoW7HNijPPISlwrT5R8sfXWtx 5og4BOYuPSHA1mESj+97rWQ+C/g+LKvpR+UxXXiD8fFIdasLCyu44rG+GoQSQxS+sE9Mq0ihmjZe T0ZK0O+WwkSNxTiZscYn0niFJfk2p2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV7b/zjx/vFrf8Axlg/ 4i+a3X8w9D2N9Eve9ezXu5dirsVdirdB4j8cVdQeI/HFXUHiPxxV1B4j8cVdQeI/HFXmfmb8tPyw udUlnur86ZcyEvNb288aLybckpIknGvtQZmY9TkArm63P2dhnKz6T5JT/wAqq/Kj/qYLj/pIt/8A qjk/zeXuDT/JWD+dL5j9S1vyu/KZTQ+YLn6J4D+qDD+by9wX+SsH86XzH6m1/Kz8p2FR5gufpuIB +uDB+by9wX+SsH86XzH6m/8AlVX5Uf8AUwXH/SRb/wDVHH83l7gv8lYP50vmP1O/5VV+VH/UwXH/ AEkW/wD1Rx/N5e4L/JWD+dL5j9SN1n8tfyzvNVurq812eK6mkLzRrPAoVj1ABiJ/HIw1OQCgGzL2 dinIyJNn3fqQX/Kqvyo/6mC4/wCki3/6o5L83l7g1/yVg/nS+Y/U7/lVX5Uf9TBcf9JFv/1Rx/N5 e4L/ACVg/nS+Y/U7/lVX5Uf9TBcf9JFv/wBUcfzeXuC/yVg/nS+Y/U7/AJVV+VH/AFMFx/0kW/8A 1Rx/N5e4L/JWD+dL5j9Tv+VVflR/1MFx/wBJFv8A9UcfzeXuC/yVg/nS+Y/U7/lVX5Uf9TBcf9JF v/1Rx/N5e4L/ACVg/nS+Y/UjLH8k/wAu78ObLVry4EdA5jmgalelaQ+2A63IOYCR2RhPIy+z9SK/ 6F/8m/8ALbqH/IyH/qhg/PT7gn+R8XfL7P1O/wChf/Jv/LbqH/IyH/qhj+en3Bf5Hxd8vs/U7/oX /wAm/wDLbqH/ACMh/wCqGP56fcF/kfF3y+z9Tv8AoX/yb/y26h/yMh/6oY/np9wX+R8XfL7P1O/6 F/8AJv8Ay26h/wAjIf8Aqhj+en3Bf5Hxd8vs/U7/AKF/8m/8tuof8jIf+qGP56fcF/kfF3y+z9Tv +hf/ACb/AMtuof8AIyH/AKoY/np9wX+R8XfL7P1O/wChf/Jv/LbqH/IyH/qhj+en3Bf5Hxd8vs/U yjyZ5D0fylFdR6bPPKt2yNIbhkYgoCBx4JH/ADZRmznJzczTaSOEERvfvZJQeI/HKXKdQeI/HFXU HiPxxV1B4j8cVY/quqearXUpFsdJjv8ATxECjet6Mhl4SORUhwV+BV6Ddh2rQgBCFn1zzosvKLQw YuIb0GkUsfgqR6oagJaq7x7dd60BoJaj8w+c2CI/lzg0nImX6wjLGPiKhloC3RRsR1rt0xoIU7rz N5yszcM/lxruFC5heCShZVMnH4AJWJbig2HevTGgqcadqOr3uk3FxPYHT7weoLeBn9QsAtY3NVQj kf2SKjB1V4dK8ryu8pLSsxMjNuxYncmvfM9wSzPRlkl0+zgj0e3nlT0pJZjIquyGVli51RgoZpCT /kjfoMplz5t0eXJXj07Ubbk/6LgCUMrxzSIwRpTHxqBGDQGJ9h4nfxFjvTR7kHqOi3tzbLamxisr ouGeQyrxZo+FrIFRIwAvMK1OW3KvfJCQQYksYv8AT57J4klKt6sayoyGoKsSOtPbf7uuWA21EUhs LFkFzBo83mXUl1W5e1gDOY5EUsS/NfhICv8As8srBPCKbSBxG10dh5KkqG1KeAhuILI0gI415bRr QV2pjcu5aj3qSaf5T9ecSapJ6A9P6uyxvyILkSBgYxuFof69MNy7kVHvRA07yP6gB1WYISd/TfYB xSv7rule3X8Rcu5NQ71sun+SRG3p6pM0gDFaxsFJHPiP7vavw/jjcu5aj3scyxqdir0n8pP959T/ ANeL9TZj5+jk4Or0DMdvdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVaZlVSzEBQKknYADF XkfmHzD5TvNSllh0b1qseVz6zw+of5uCim/j1PfMuEJAc3FlOJPJFWkcr2NtPb6LKto7J9VIv5VX lKzxjiOxqrA/24Dz5/YkcuX2rYo7m4ZRbWDIYmMSx/pCTkpQpWgJ2A5p+GPx+xPw+1Dz3MdjCbi5 0xwVkVPUF/LXmUSVaca9F4Gv9MNX1+xiTXT7UBNrmhzuHn0hpXAChnvJmNB0FSMlwnvYmQ7lP9Ke XP8Aqx/9PUv9MeE968Ue5Ha5qWgJq92suj+rIJWDSfWZF5GvWgG2RiDXNlIi+SB/Snlz/qx/9PUv 9MlwnvY8Ue536U8uf9WP/p6l/pjwnvXij3O/Snlz/qx/9PUv9MeE968Ue536U8uf9WP/AKepf6Y8 J714o9zv0p5c/wCrH/09S/0x4T3rxR7nfpTy5/1Y/wDp6l/pjwnvXij3M8/LW606eC/NlZfUwrR8 x6rS8qhqfa6UyjMDtbdiI6M0yludirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVU7mBZ7aWB iQsqMhI6gMKYhXiGo+VdesLp7eSymk4k8ZYkZ0YdiGUHM0TBcIwIT7SbZora1W5bU4fT4/uoVuRx fnWQ7KFVTGCi8Kn4t8hI+5siPerywaXwUM+pmUxhf3ouQDUqHD0U0BCD7NensMFnyTQ81N7XTphH bFdTurJDxCzLcFUCyr6fFVFNoGKnbqu3XDZ8loeaRatoUyzRfo+zuXjMSmX9zNtJvyALqpPj09t+ pnGXe1yj3IL9Caz/AMsFz/yKf+mS4h3seE9yeXS63Y69qU9vprXC3HqRVkgd14sQeS0pvt8srFED dsNgnZe+seZWeKT9Br6kMhmRzbzk8+XJSasa8e1ceGPevFLuWJqfmNJmlGhRnkkcfA2spUCIsVIB PX4qH5DGh3rxS7l0WreZEeR20KOVpftmS1mO3N3AoGA29Ur8qeGNR714pdyo+u+aGDV0KIMwYM62 kob4mDVqD2IFMeGPevFLuWjWfM/psh0ONuYKsWtZSdwBXc9fh6/2Y8Me9eKXcx/9Caz/AMsFz/yK f+mWcQ72vhPc9C/KyzvLaDURcwSQFni4iRGStA3TkBmPmN05GEEWzrKG52KuxV2KuxV2KuxV2Kux V2KuxV2KuxVF+nH/ACjFXenH/KMVS+TXfL0bOr3tuGjZkdeakhk+1UD+XoffDSqg1TRjcJbC5h+s ScfTi5rybmpZaDqaqK/LBSrhqWkMEIuYSJDRCHWhPHnTr1474q22oaSqszXMAVV5sea7LQNXr4MD 9OKrhdaeXVBLFzegROS8iWHIADruu+KoMeY/LRUML+2oaUPNejGin5Hxw0qvNqmjQxTSyXUCx2/L 1zzU8OJ4sGoeoIpTxwUq46hpIRn+swlUAZiHU0BUuDse6jkPbFVwvdMLiMXEPqMCVTmtSAeJIFf5 tsVUp9X0S3/vrqBPh5irLuvLjUU67mmNKuuNS0e34evdQRCVmWMu6gEoaONz+ydj77YqprregtDJ MLuD0oSqyuWACl/shielcNKqw6jpM3D0riF/VJWKjL8RUlSF8dwcCuj1LSJIklS5gMcgVkbmtCGr x79+J+7FVy3umM7Is8RZOHL4l29SvAV8WptirTahpKiNmuYAsoLRMXWjBepBruBTFW473TJJmhjn ieVSAyKykgtUgfM8TtiqkNX0Qici7g/0ZuM/xr8LcPUod/5N8NKqm+0pY1lNxAI25cXLpxPA0ahr 274FU4tV0SV5Uju4HaH+9AdTxoaGpr2Ox8MaV0uqaNFHcSPcwqlrUXB5D4CBUg/fjSrjqWjheRu7 cL0r6iUrTl4+G+KtvqGkInN7qBUpXkZEApvvWv8Akn7sVWvqmjJ6nK7gX0gDJV02BCsCd+4dfvGN K2moaU4qJ4qceZqwFFDcKmtKfFt88Vc2paOv2rqAUNDWRNiK9d9vsH7sVWvqmjIWBuYSyMqOqsGK s7FVDBakVYED3xpWodY0SanpXULgokgYMOPGSnA8unxchTxxpUb6cf8AKMVd6cf8oxVdirsVYk3+ BPrc9fV9f0p/W/3sp9X5n1v8n0fUr0+CvTJboRWmf4O+sQ/UKep8HpcfW4cuKePwc6cOdfi6csG6 UBN/yrz6ovLn6H1lOHp/W6/WPTXhTh8VePH/AGX+Vh3Qlx/5VD6aVpxp+6/3srXjH9jvy48Om+O6 p5b/AOCP01N6VP0n/o/qV9f+dPR48vgry4/Z+nvg3SlcP/KqfraU9L6xzb+++sdfVSvqertx9TjT lt1p3w7oVta/5Vr+lJv0nT9IenJ6n+9XL0+Unq8fT248ufLj3xFq67/5Vn9buPW4+v6p+s8PrNOf IdeHw05Up26U7Y7pSm1/5V9/iix+qfW+XOH6vXj9W51b0f77/SP7zw9q/DTDvSEV/wAgj9M04cfr K/Z+tV9fjtSm9KeHw198G6o9v+Vb/o2OvH9H85/s/WOHL1I/W9Xj29T0/t7VpTHdVaf/AAL6l39Z 5/WeMP1r1vrf1jjxb0/t/vfs8uXHt9rbHdKvb/4O56bw5+r6z/o/1PrXqetzf1OXqfFXnz5c/euD dUh/5BJ9VTly9D0T6fP6/wD3VH5UrvSnOv04d0I23/5Vp+j4/q9PqPrw+lw+tcPU4y+nxp+zx9St Ph61x3VEXH/KvfrFn6vH1OD/AFXj9Y48PWblXj8NPV5U5e9Nsd0pT5S/5Vt9Y/0H1PV+vf6H9ar/ AHtP3fp8f2afZ9T4vHtibQFe5/5VX9RPr8vqnKLl/vb19FPSrT4qelx412/HHdUZe/8AKu/R0z6z /cep/uOp9a9Pn8H8vw1+z9r+uO6UJN/yqzgPU5ceY4/72/br8PGnfwpjuhEaT/gT9M3f1Dn6v1ce tX1PT4eov2eX7zrwp+zT7P7WJtUtm/5Vt/ijSfT9b61xT0acvq/D019H1PW+Ljwpx9Pan2tsd6VE W3/KpOX7n0uXPv8AWftcz/N/lVx3VF3v+Af0vN9f9X9Ibfb+s8uHoJ/J/kVrz+KvP3x3Vbef8q8/ 3Jep/vL6L/X/AKv6vp8OUHqcfQ+Pj/dV4fD9rvzx3VLtF/5Vt6dv6v1j1uT/AFb656laeqOVPR/c /wB79P0UxNqyLRP8HehJ+i+Xoc4Of+9HHn659Gnqf8XV6fTgNpSo/wDKrPq5p6fDmtOH1jnyo9OP H46fa5U28d6Yd0M5yKXYq//Z 34.521363 13.899444 Centimeters 1 False False Cyan Magenta Yellow Black Groupe de nuances par défaut 0 Blanc CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Noir CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 Rouge CMJN CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 Jaune CMJN CMYK PROCESS 0.000000 0.000000 100.000000 0.000000 Vert CMJN CMYK PROCESS 100.000000 0.000000 100.000000 0.000000 Cyan CMJN CMYK PROCESS 100.000000 0.000000 0.000000 0.000000 Bleu CMJN CMYK PROCESS 100.000000 100.000000 0.000000 0.000000 Magenta CMJN CMYK PROCESS 0.000000 100.000000 0.000000 0.000000 C=15 M=100 J=90 N=10 CMYK PROCESS 15.000000 100.000000 90.000000 10.000000 C=0 M=90 J=85 N=0 CMYK PROCESS 0.000000 90.000000 85.000000 0.000000 C=0 M=80 J=95 N=0 CMYK PROCESS 0.000000 80.000000 95.000000 0.000000 C=0 M=50 J=100 N=0 CMYK PROCESS 0.000000 50.000000 100.000000 0.000000 C=0 M=35 J=85 N=0 CMYK PROCESS 0.000000 35.000000 85.000000 0.000000 C=5 M=0 J=90 N=0 CMYK PROCESS 5.000000 0.000000 90.000000 0.000000 C=20 M=0 J=100 N=0 CMYK PROCESS 20.000000 0.000000 100.000000 0.000000 C=50 M=0 J=100 N=0 CMYK PROCESS 50.000000 0.000000 100.000000 0.000000 C=75 M=0 J=100 N=0 CMYK PROCESS 75.000000 0.000000 100.000000 0.000000 C=85 M=10 J=100 N=10 CMYK PROCESS 85.000000 10.000000 100.000000 10.000000 C=90 M=30 J=95 N=30 CMYK PROCESS 90.000000 30.000000 95.000000 30.000000 C=75 M=0 J=75 N=0 CMYK PROCESS 75.000000 0.000000 75.000000 0.000000 C=80 M=10 J=45 N=0 CMYK PROCESS 80.000000 10.000000 45.000000 0.000000 C=70 M=15 J=0 N=0 CMYK PROCESS 70.000000 15.000000 0.000000 0.000000 C=85 M=50 J=0 N=0 CMYK PROCESS 85.000000 50.000000 0.000000 0.000000 C=100 M=95 J=5 N=0 CMYK PROCESS 100.000000 95.000000 5.000000 0.000000 C=100 M=100 J=25 N=25 CMYK PROCESS 100.000000 100.000000 25.000000 25.000000 C=75 M=100 J=0 N=0 CMYK PROCESS 75.000000 100.000000 0.000000 0.000000 C=50 M=100 J=0 N=0 CMYK PROCESS 50.000000 100.000000 0.000000 0.000000 C=35 M=100 J=35 N=10 CMYK PROCESS 35.000000 100.000000 35.000000 10.000000 C=10 M=100 J=50 N=0 CMYK PROCESS 10.000000 100.000000 50.000000 0.000000 C=0 M=95 J=20 N=0 CMYK PROCESS 0.000000 95.000000 20.000000 0.000000 C=25 M=25 J=40 N=0 CMYK PROCESS 25.000000 25.000000 40.000000 0.000000 C=40 M=45 J=50 N=5 CMYK PROCESS 40.000000 45.000000 50.000000 5.000000 C=50 M=50 J=60 N=25 CMYK PROCESS 50.000000 50.000000 60.000000 25.000000 C=55 M=60 J=65 N=40 CMYK PROCESS 55.000000 60.000000 65.000000 40.000000 C=25 M=40 J=65 N=0 CMYK PROCESS 25.000000 40.000000 65.000000 0.000000 C=30 M=50 J=75 N=10 CMYK PROCESS 30.000000 50.000000 75.000000 10.000000 C=35 M=60 J=80 N=25 CMYK PROCESS 35.000000 60.000000 80.000000 25.000000 C=40 M=65 J=90 N=35 CMYK PROCESS 40.000000 65.000000 90.000000 35.000000 C=40 M=70 J=100 N=50 CMYK PROCESS 40.000000 70.000000 100.000000 50.000000 C=50 M=70 J=80 N=70 CMYK PROCESS 50.000000 70.000000 80.000000 70.000000 Gris 1 C=0 M=0 J=0 N=100 CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 C=0 M=0 J=0 N=90 CMYK PROCESS 0.000000 0.000000 0.000000 89.999400 C=0 M=0 J=0 N=80 CMYK PROCESS 0.000000 0.000000 0.000000 79.998800 C=0 M=0 J=0 N=70 CMYK PROCESS 0.000000 0.000000 0.000000 69.999700 C=0 M=0 J=0 N=60 CMYK PROCESS 0.000000 0.000000 0.000000 59.999100 C=0 M=0 J=0 N=50 CMYK PROCESS 0.000000 0.000000 0.000000 50.000000 C=0 M=0 J=0 N=40 CMYK PROCESS 0.000000 0.000000 0.000000 39.999400 C=0 M=0 J=0 N=30 CMYK PROCESS 0.000000 0.000000 0.000000 29.998800 C=0 M=0 J=0 N=20 CMYK PROCESS 0.000000 0.000000 0.000000 19.999700 C=0 M=0 J=0 N=10 CMYK PROCESS 0.000000 0.000000 0.000000 9.999100 C=0 M=0 J=0 N=5 CMYK PROCESS 0.000000 0.000000 0.000000 4.998800 Couleurs vives 1 C=0 M=100 J=100 N=0 CMYK PROCESS 0.000000 100.000000 100.000000 0.000000 C=0 M=75 J=100 N=0 CMYK PROCESS 0.000000 75.000000 100.000000 0.000000 C=0 M=10 J=95 N=0 CMYK PROCESS 0.000000 10.000000 95.000000 0.000000 C=85 M=10 J=100 N=0 CMYK PROCESS 85.000000 10.000000 100.000000 0.000000 C=100 M=90 J=0 N=0 CMYK PROCESS 100.000000 90.000000 0.000000 0.000000 C=60 M=90 J=0 N=0 CMYK PROCESS 60.000000 90.000000 0.003100 0.003100 image/svg+xml

OCS-01: A potential paradigm
shift in DME treatment

Our most advanced product candidate, OCS-01, is in clinical trials in patients with DME and in planning phase for potential front-of-the-eye indications.

 

OCS-01 has been developed from Oculis’ solubilizing nanoparticle (SNP) technology, a proprietary platform that enables the formulation of drugs as non-invasive topical treatments and enhances their bioavailability in the relevant eye tissues. If approved in DME, it has the potential to provide a new option for patients.

OCS-01: A potential treatment
for Post-cataract Surgery Inflammation

 

Because patients undergoing cataract surgery are usually on several medications daily, adding more eye drops can be challenging. A long-acting topical solution such as OCS-01 has the potential of reducing the frequency of the burden of administration to patients.

OCS-02: THE POTENTIAL OF
topical anti-TNF alpha
therapy for ophthalmic
indications

The compound, named OCS-02, is based on a proprietary single-chain antibody fragment technology specifically designed for topical delivery. Efficacy and safety were evaluated in three clinical trials including two controlled studies under IND. The studies demonstrated a promising profile for treating inflammatory conditions of the anterior segment of the eye including Uveitis and Dry Eye Disease.